$BTMD Income Statement | Understand Stock

$BTMD

$1.18 +$0.03 (2.61%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating and formation costs
Franchise tax expense
Revenue
Product Revenue
Service Revenue
Total revenue
Cost of revenue
Product Revenue
Service Revenue
Total cost of revenue
Commissions
Marketing
Selling, general, and administrative
Income from operations
Transaction costs allocated to warrant liabilities
Net gain on investments held in Trust Account
Excess of private placement warrant fair value over purchase price
Other income (expense) net :
Interest expense, net
Loss from change in fair value of warrant liability
Gain (loss) from change in fair value of earnout liabilities
Loss from extinguishment of debt
Other income
Other income (expense), net
Total other income (expense), net

Income before provision for income taxes
Income tax expense
Net income
Less: Net income (loss) attributable to noncontrolling interest
Net income attributable to biote Corp. stockholders
Basic and diluted weighted average shares outstanding
Other comprehensive income (loss):
Foreign currency translation adjustments
Other comprehensive income (loss)
Comprehensive income attributable to biote Corp. stockholders
Net income per common share
Basic
Common Class A
Common Class B
Total basic

Diluted
Common Class A
Common Class B
Total diluted

Weighted average common shares outstanding
Basic
Common Class A
Common Class B
Total basic

Diluted
Common Class A
Common Class B
Total diluted

Comments